Prolonged Viral Shedding of SARS-CoV-2 in Patients With Underlying Haemato-oncological Disease
In Vivo · 2025
DOI: 10.21873/invivo.13887 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, 2025. Verfasst von Alexander Casimir Angleitner und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany alexander.angleitner@med.uni-goettingen.de. Hauptthemen laut MEDLINE: Virus Shedding, COVID-19, SARS-CoV-2, Hematologic Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany alexander.angleitner@med.uni-goettingen.de.
- Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany.
Zitieren
APA
Angleitner, A. C., Levien, L., & Büntzel, J. (2025). Prolonged Viral Shedding of SARS-CoV-2 in Patients With Underlying Haemato-oncological Disease. In Vivo. https://doi.org/10.21873/invivo.13887
Vancouver
Angleitner AC, Levien L, Büntzel J. Prolonged Viral Shedding of SARS-CoV-2 in Patients With Underlying Haemato-oncological Disease. In Vivo. 2025. doi:10.21873/invivo.13887
BibTeX
@article{Angleitner2025,
author = {Angleitner, Alexander Casimir and Levien, Lena and Büntzel, Judith},
title = {Prolonged Viral Shedding of SARS-CoV-2 in Patients With Underlying Haemato-oncological Disease},
journal = {In Vivo},
year = {2025},
doi = {10.21873/invivo.13887}
}
EUVIMED